News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 252 results

Personal Genomics takes PacBio dispute to Chinese court

China22-05-2020Rory O'Neill

Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.

Natera and Illumina settle litigation, agree mutual licence

14-05-2020

Natera has agreed to license Illumina IP covering non-invasive prenatal testing (NIPT), in a deal that sees the pair settle all outstanding patent litigation over the technology.

Merck expands CRISPR patent portfolio

US12-05-2020Rory O'Neill

Merck has added two US patents to its CRISPR-Cas9 patent portfolio, and is already seeking licensing and product development partners, the German company announced yesterday, May 11.

Merck KGaA secures second US CRISPR patent

US09-04-2020Sarah Morgan

Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23. 

EIP boosts life sciences practice with Mathys & Squire partner

UK02-04-2020

IP law firm EIP has enhanced its life science capabilities with the addition of Monika Rai as a partner. 

Webinar: Plenty to fight for in CRISPR IP battle

US26-03-2020

Despite a recent swing in momentum to the University of California, it’s still too early to say who is likely to emerge triumphant in the CRISPR patent battle.

PacBio pledges to fight invalidation of patents after bitter dispute

US19-03-2020Rory O'Neill

California-based Pacific Biosciences has accused a UK rival of exploiting the coronavirus pandemic in a patent infringement trial.

Fed Circuit restores two Illumina DNA patents in blow to Roche

US19-03-2020Rory O'Neil

The US Court of Appeals for the Federal Circuit has ruled that two Illumina DNA detection patents are valid, in a reversal of a California district court.

Biogen blocking bid rejected; signs $2.4bn deal

US28-02-2020Sarah Morgan

The US Court of Appeals for the Federal Circuit has rejected Biogen’s bid to block a bioequivalent version of its multiple sclerosis drug, pending an appeal against a lower court’s ruling.

University of California gains ground after EPO backs CRISPR patent

EU11-02-2020Sarah Morgan

In a victory for the University of California, the European Patent Office has affirmed a CRISPR patent issued to Emmanuelle Charpentier, the University of California, and the University of Vienna.

Showing 1 to 10 of 252 results

LSIPR